Investigating Distress Tolerance in Adults With Tourette Syndrome
1 other identifier
interventional
9
1 country
1
Brief Summary
Although behavior therapy is recognized as a first-line intervention for Tourette's Disorder (TD), less than 40% of adults with TD respond to this evidence-based treatment. Limited tolerance for aversive premonitory urges and affective states that accompany tics may be one likely factor that impedes behavior therapy outcomes. This study examines the relationship between distress tolerance and tic inhibition among adults with TD, and investigates the mechanism and effect of therapeutic skills training to enhance distress tolerance abilities. Findings will determine the optimal approach to enhance distress tolerance among adults with TD and ultimately lead to better behavior therapy outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 13, 2021
CompletedFirst Posted
Study publicly available on registry
September 17, 2021
CompletedStudy Start
First participant enrolled
June 2, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 28, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 28, 2024
CompletedJune 7, 2024
June 1, 2024
2 years
September 13, 2021
June 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Distress Tolerance Scale (DTS)
The Distress Tolerance Scale is a 15-item self-report measure that measures the perceived capacity to tolerate distress from a multidimensional framework, including tolerance, appraisal, absorption, and regulation. Items are rated on a 1-5 Likert scale, and then summed. Score ranges from 15-75. Higher total scores indicate greater difficulty with tolerating distress.
Within 1 week after completion of Distress Tolerance Skills Training
Secondary Outcomes (1)
Yale Global Tic Severity Scale-Revised (YGTSS)
Within 1 week after completion of Distress Tolerance Skills Training
Study Arms (1)
Distress Tolerance Skills Training
EXPERIMENTALDistress tolerance skills training is a multicomponent intervention drawn from third-wave cognitive-behavioral therapy (CBT) protocols.
Interventions
Individuals with TS will receive distress tolerance skill training. Therapeutic skill training will consist of 4 weekly 1-hour sessions. Skill training will occur either in-person or remotely via videoconferencing software. Sessions will focus on building participants' distress tolerance skills with strategies drawn from third-wave CBT.
Eligibility Criteria
You may qualify if:
- at least 18 years of age
- have moderate tic severity or greater as evidenced by a YGTSS Total Tic Score greater than 14 (\>9 for adults with motor or vocal tics only)
- exhibit a tic frequency of at least one visible tic per minute
- be fluent in English
- have a total premonitory urge for tics scale (PUTS) total score greater than 17 at Visit 2
- have a total DTS score greater than 30 at Visit 2
You may not qualify if:
- history of cardiovascular disorder
- history of fainting or seizures
- history of frostbite
- open cut or sore on hand to be immersed
- fracture to the limb to be immersed
- history of Reynaud's phenomenon
- inability to complete rating scales
- inability to attend study visits
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Johns Hopkins Universitylead
- Tourette Association of Americacollaborator
Study Sites (1)
Johns Hopkins University School of Medicine
Baltimore, Maryland, 21287, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joseph F. McGuire, Ph.D.
Johns Hopkins University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 13, 2021
First Posted
September 17, 2021
Study Start
June 2, 2022
Primary Completion
May 28, 2024
Study Completion
May 28, 2024
Last Updated
June 7, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share